Edoxaban Monotherapy in Nonvalvular Atrial Fibrillation Patients with Coronary Artery Disease

Figure 1

Flowchart showing the enrollment, randomization, and follow-up of the study patients. The patients were randomly assigned at a 1 : 1 ratio to receive a monotherapy with edoxaban or a combination therapy with edoxaban and clopidogrel.